印度品牌价值基金会（IBEF）：2025印度医疗器械产业研究报告（英文版）（35页）.pdf

1、For updated information,please visit www.ibef.orgAugust 2025Medical Devices2Table of ContentsExecutive Summary3Advantage India 4Market Overview 6Growth Drivers12Recent Trends17Export Scenario23Manufacturing Cluster25Major Investments27Key Industry Contacts31Appendix333The Drugs Controller General of

2、 India(DCGI),Dr.Rajeev Raghuvanshi,announced that 11 countries have already recognized Indian pharmacopoeiaas their standard.He highlighted that India supplies drugs,vaccines,andmedical devices to over 200 countries globally and is now approving,onaverage,100 global clinical trials annually,reflecti

3、ng the trust internationalresearch organizations and companies place in Indias regulatory system.Indias medical device industry is valued at around Rs.94,017-1,02,564 crore(US$11-12billion)in FY24 and accounts for roughly 1.6%of the globalmarket.Policy-makers expect the sector to expand to about US$

4、50billion by2030.Indias drugs&pharma exports rose 59%from Rs.1.55 lakh crore(US$17.12 billion)in FY19 to Rs.2.47 lakh crore(US$28.90 billion)in FY25,whilemedical device exports surged 88%from FY19 to Rs.31,120 crore(US$3.64billion),supported by government schemes including the Rs.3,420 crore(US$400

5、million)PLI Scheme.The global market share of the medical device industry in India is expected togrow from 1.65%(2023-24)to 10%-12%within 25 years.India is the fourth largest Asian medical devices market after Japan,China,and South Korea,and among the top 20 medical devices markets globally.The Indi

6、an medical device market is segmented into five key areas:electronicequipment(56%share),disposables&consumables(26.5%),in-vitrodiagnostics(8.1%),implants(7.1%),and surgical instruments(2.3%).Source:Government Website,EY,News Articles15.3512.0050.000.0010.0020.0030.0040.0050.0060.00202320242030E2.923